These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 11714562)

  • 1. Serum and cerebrospinal fluid nitrite and nitrate levels in relapsing-remitting and secondary progressive multiple sclerosis patients.
    Yuceyar N; Taşkiran D; Sağduyu A
    Clin Neurol Neurosurg; 2001 Dec; 103(4):206-11. PubMed ID: 11714562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CSF nitric oxide metabolites are associated with activity and progression of multiple sclerosis.
    Rejdak K; Eikelenboom MJ; Petzold A; Thompson EJ; Stelmasiak Z; Lazeron RH; Barkhof F; Polman CH; Uitdehaag BM; Giovannoni G
    Neurology; 2004 Oct; 63(8):1439-45. PubMed ID: 15505162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebrospinal fluid and serum levels and intrathecal production of active matrix metalloproteinase-9 (MMP-9) as markers of disease activity in patients with multiple sclerosis.
    Fainardi E; Castellazzi M; Bellini T; Manfrinato MC; Baldi E; Casetta I; Paolino E; Granieri E; Dallocchio F
    Mult Scler; 2006 Jun; 12(3):294-301. PubMed ID: 16764342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Raised cerebrospinal fluid nitrite and nitrate levels in patients with multiple sclerosis: no correlation with disease activity.
    Drulović J; Dujmović I; Mesaros S; Samardzić T; Maksimović D; Stojsavljević N; Lević Z; Mostarica Stojokvić M
    Mult Scler; 2001 Feb; 7(1):19-22. PubMed ID: 11321188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased nitric oxide products in CSF in primary progressive MS may reflect brain atrophy.
    Peltola J; Ukkonen M; Moilanen E; Elovaara I
    Neurology; 2001 Sep; 57(5):895-6. PubMed ID: 11552025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in levels of oxidative stress markers and some neuronal enzyme activities in cerebrospinal fluid of multiple sclerosis patients.
    Bartova R; Petrlenicova D; Oresanska K; Prochazkova L; Liska B; Turecky L; Durfinova M
    Neuro Endocrinol Lett; 2016; 37(2):102-6. PubMed ID: 27179571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood circulating microparticle species in relapsing-remitting and secondary progressive multiple sclerosis. A case-control, cross sectional study with conventional MRI and advanced iron content imaging outcomes.
    Alexander JS; Chervenak R; Weinstock-Guttman B; Tsunoda I; Ramanathan M; Martinez N; Omura S; Sato F; Chaitanya GV; Minagar A; McGee J; Jennings MH; Monceaux C; Becker F; Cvek U; Trutschl M; Zivadinov R
    J Neurol Sci; 2015 Aug; 355(1-2):84-9. PubMed ID: 26073484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum and cerebrospinal fluid concentrations of homoarginine, arginine, asymmetric and symmetric dimethylarginine, nitrite and nitrate in patients with multiple sclerosis and neuromyelitis optica.
    Haghikia A; Kayacelebi AA; Beckmann B; Hanff E; Gold R; Haghikia A; Tsikas D
    Amino Acids; 2015 Sep; 47(9):1837-45. PubMed ID: 26055922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased cerebrospinal fluid and serum nitrite and nitrate levels in amyotrophic lateral sclerosis.
    Taskiran D; Sagduyu A; Yüceyar N; Kutay FZ; Pögün S
    Int J Neurosci; 2000; 101(1-4):65-72. PubMed ID: 10765991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transferrin in patients with multiple sclerosis: a comparison among various subgroups of multiple sclerosis patients.
    Zeman D; Adam P; Kalistová H; Sobek O; Kelbich P; Andel J; Andel M
    Acta Neurol Scand; 2000 Feb; 101(2):89-94. PubMed ID: 10685854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CXCL10 and CXCL13 chemokines in patients with relapsing remitting and primary progressive multiple sclerosis.
    Iwanowski P; Losy J; Kramer L; Wójcicka M; Kaufman E
    J Neurol Sci; 2017 Sep; 380():22-26. PubMed ID: 28870573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of biomarkers for diagnosis and progression of MS by MALDI-TOF mass spectrometry.
    Teunissen CE; Koel-Simmelink MJ; Pham TV; Knol JC; Khalil M; Trentini A; Killestein J; Nielsen J; Vrenken H; Popescu V; Dijkstra CD; Jimenez CR
    Mult Scler; 2011 Jul; 17(7):838-50. PubMed ID: 21505015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Astrocytic activation in relation to inflammatory markers during clinical exacerbation of relapsing-remitting multiple sclerosis.
    Rejdak K; Petzold A; Kocki T; Kurzepa J; Grieb P; Turski WA; Stelmasiak Z
    J Neural Transm (Vienna); 2007; 114(8):1011-5. PubMed ID: 17393066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tau protein seems not to be a useful routine clinical marker of axonal damage in multiple sclerosis.
    Guimarães I; Cardoso MI; Sá MJ
    Mult Scler; 2006 Jun; 12(3):354-6. PubMed ID: 16764350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of lithium serum level in multiple sclerosis patients: A neuroprotective element.
    Karimi A; Bahrampour K; Momeni Moghaddam MA; Asadikaram G; Ebrahimi G; Torkzadeh-Mahani M; Esmaeili Tarzi M; Nematollahi MH
    Mult Scler Relat Disord; 2017 Oct; 17():244-248. PubMed ID: 29055468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrathecal IgM index correlates with a severe disease course in multiple sclerosis: Clinical and MRI results.
    Ozakbas S; Cinar BP; Özcelik P; Baser H; Kosehasanoğullari G
    Clin Neurol Neurosurg; 2017 Sep; 160():27-29. PubMed ID: 28622533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human kallikrein 6 cerebrospinal levels are elevated in multiple sclerosis.
    Hebb AL; Bhan V; Wishart AD; Moore CS; Robertson GS
    Curr Drug Discov Technol; 2010 Jun; 7(2):137-40. PubMed ID: 20836755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chitinase effects on immune cell response in neuromyelitis optica and multiple sclerosis.
    Correale J; Fiol M
    Mult Scler; 2011 May; 17(5):521-31. PubMed ID: 21159721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor necrosis factor-alfa and interleukin-4 in cerbrospinal fluid and plasma in different clinical forms of multiple sclerosis.
    Obradović D; Kataranovski M; Dincić E; Obradović S; Colić M
    Vojnosanit Pregl; 2012 Feb; 69(2):151-6. PubMed ID: 22500369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated cerebrospinal fluid and serum nitrate and nitrite levels in patients with central nervous system complications of HIV-1 infection: a correlation with blood-brain-barrier dysfunction.
    Giovannoni G; Miller RF; Heales SJ; Land JM; Harrison MJ; Thompson EJ
    J Neurol Sci; 1998; 156(1):53-8. PubMed ID: 9559987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.